Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Inhibitory Effect of Tetraethylammoniumbromide in Alloxan Diabetes

Nature volume 169, pages 586–587 (1952)Cite this article

Abstract

THE mechanism of the effect of alloxan has been examined thoroughly by several investigators. For example, Abderhalden1 found that if the application of alloxan was preceded by an injection of cysteine, he was able to prevent diabetes. Brückmann and Wertheimer2 found that the level of reduced glutathione in the blood fell after an injection of alloxan. In our previous work3, we showed that alloxan reacts with SH-groups of blood proteins; this was proved polarographically. Further, we found that we could trace the fall of reduced glutathione not only in the blood but also, after a longer period of time following the injection of alloxan, in the pancreas, liver and, mainly, in the adrenals4.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  1. Abderhalden, Z. Vitamin-, Fermet- u. Hormonforsch., 1, 241 (1947).

    CAS  Google Scholar 

  2. Brückmann and Wertheimer, J. Biol. Chem., 168, 241 (1947).

    PubMed  Google Scholar 

  3. Brada, Z., Biochem. et Biophys. Acta, 3, 427 (1949).

    Article  CAS  Google Scholar 

  4. Brada, Z., Arch. Int. Pharmacodyn., 85, 497 (1951).

    CAS  PubMed  Google Scholar 

  5. Jimenez-Diaz, C., Grande-Covian, F., and De Oya, J. C., Nature, 158, 589 (1946).

    Article  ADS  CAS  PubMed  Google Scholar 

  6. Int. Physiol. Congr. Oxford (1947).

  7. Houssay, B. A., and Martínez, C., Nature, 162, 571 (1948).

    Article  ADS  CAS  PubMed  Google Scholar 

  8. Gold, A., Nature, 159, 574 (1947).

    Article  ADS  CAS  PubMed  Google Scholar 

  9. Duff, J. L., Wilson, D. C., and McMillan, G. C., Nature, 159, 575 (1947).

    Article  ADS  CAS  PubMed  Google Scholar 

  10. Lazarow, A., Proc. Soc. Exp. Biol. Med., 66, 4 (1947). Lazarow, A., Patterson, J. W., and Lewey, S., Science, 108, 308 (1948). Patterson, J. W., Lazarow, A., and Lewey, S., J. Biol. Chem., 177, 197 (1949).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Research Department, Masaryk State Institute for Radiotherapy, Brno

    Z. BRADA

Authors
  1. Z. BRADA
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

BRADA, Z. Inhibitory Effect of Tetraethylammoniumbromide in Alloxan Diabetes. Nature 169, 586–587 (1952). https://doi.org/10.1038/169586b0

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/169586b0

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing